Cargando…
Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study
Evidence indicates that type 2 diabetes may stimulate the initiation and progression of several types of cancer. Metformin, a drug most commonly used to treat type 2 diabetes, may inhibit cancer cell growth and reduce the risk of cancer. However, evidence of the antitumor effects of metformin on ova...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521948/ https://www.ncbi.nlm.nih.gov/pubmed/28723808 http://dx.doi.org/10.1097/MD.0000000000007605 |